Ronald Rittenmeyer - Iqvia Holdings Director

<div class='circular--portrait' style='background:#0D52D1;color: white;font-size:5em;padding-top: 5px;;'>Q</div>
  Director
Mr. Ronald A. Rittenmeyer is an Independent Director of the Company. Prior to his role at the Company, Mr. Rittenmeyer served as a Director of IMS Health from April 2010 to October 2016. He is the past Chairman, President and CEO of Expert Global Solutions, Inc., a business process outsourcing company, from 2011 to June 2014. He is the current Chairman and CEO of Millenium Health, a leading private health solutions company. Previously, Mr. Rittenmeyer served as Chairman, CEO and President of Electronic Data Systems Corporationrationration from 2005 until 2008. Prior to that, he served as Chief Operating Officer of Electronic Data Systems Corporationrationration from October 2005 until September 2007 and as Executive Vice President, Global Service Delivery from July 2005 until December 2006. Mr. Rittenmeyer also serves on the boards of directors of American International Group, Inc. and Tenet Health Care Corporationrationration. He previously served as a director of EDS and RH Donnelley . Mr. Rittenmeyer holds a B.A. in Commerce and Economics from Wilkes University and his M.B.A. from Rockhurst University. Mr. Rittenmeyer chairs the LDCC and serves as a member of the Audit Committee.
Age: 69  Director Since 2016  MBA    
919-998-2000  www.quintiles.com
Rittenmeyer holds a B.A. in Commerce and Economics from Wilkes University and his M.B.A. from Rockhurst University.

Ronald Rittenmeyer Latest Insider Activity

Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. Iqvia Holdings has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Yun HaSK Innovation
2016
Jeong YuSK Innovation
2016
Luiz BrittoPETROBRAS PN N2
2015
Mitsuyoshi KobayashiNIPPON TEL TEL CORP
2014
Hiroki KuriyamaNIPPON TEL TEL CORP
2014
Guilherme FerreiraPETROBRAS PN N2
2015
Un ShinSK Innovation
2013
Hyeok ChoiSK Innovation
2010
Eiichi SakamotoNIPPON TEL TEL CORP
2018
Durval SantosPETROBRAS PN N2
2016
Katsuhiko KawazoeNIPPON TEL TEL CORP
2018
Segen EstefenPETROBRAS PN N2
2015
Hiroki KuriyamaNIPPON TEL TEL CORP
2014
Deyvid SilvaPETROBRAS PN N2
2015
Marcelo SiqueiraPETROBRAS PN N2
2016
Luiz CarvalhoPETROBRAS PN N2
2015
Katsuhiko ShiraiNIPPON TEL TEL CORP
2012
Sadayuki SakakibaraNIPPON TEL TEL CORP
2012
Myeong LeeSK Innovation
2019
Hiromichi ShinoharaNIPPON TEL TEL CORP
2018
Danilo SilvaPETROBRAS PN N2
2018

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Iqvia Holdings (Q) is traded on BATS Exchange in USA and employs 36,100 people.

Iqvia Holdings Leadership Team

Thomas Pike, CEO and Director
Ari Bousbib, Director
Michael Evanisko, Independent Director
Leonard Schaeffer, Independent Director
James Erlinger, Executive Vice President General Counsel, Secretary
John Danhakl, Director
Richard Staub, President - Research and Development Solutions
Michael McDonnell, CFO, Executive Vice President
Kevin Gordon, COO
John Leonard, Independent Director
James Fasano, Director
Jonathan Coslet, Director
John Connaughton, Director
Haiyuan Lo, Director
Ronald Rittenmeyer, Director
Dennis Gillings, Executive Chairman of the Board
Todd Sisitsky, Director
Jack Greenberg, Independent Director
Kevin Knightly, President - Information and Technology Solutions

Stock Performance Indicators

Current Sentiment - Q

Iqvia Holdings Investor Sentiment

More than half of Macroaxis users are at this time bullish on Iqvia Holdings. What is your judgment towards investing in Iqvia Holdings? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

USRT   
Purchased few shares of
a day ago
Traded for 55.68
IJR   
Purchased few shares of
a day ago
Traded for 85.37
IJH   
Purchased one share of
a day ago
Traded for 209.15
IVV   
Purchased one share of
a day ago
Traded for 333.5
IDEV   
Purchased few shares of
a day ago
Traded for 59.01
See also Your Equity Center. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.